tirzepatide studies 2025 on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Outlook for obesity in 2025:
Description
Like other weight loss drugs, tirzepatide promotes weight loss by affecting certain brain chemicals involved in food intake, energy expenditure, and fat deposition
Tirzepatide stands apart from other commonly prescribed weight loss medications due to its innovative dual mechanism of action
For example, it shows promise for people in East Asian and Hispanic/Latino populations, Dr
The Eating Disorder Screen for Primary Care (ESP) takes under 5 minutes and can be administered in-office
Keep reading to find out
